Filing Details

Accession Number:
0001562180-22-006567
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-08 20:00:37
Reporting Period:
2022-09-07
Accepted Time:
2022-09-08 20:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1767584 Hongbo Lu C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-07 600,000 $3.60 3,581,592 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.